A4016512
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate , 97% , 161797-99-5
CAS NO.:161797-99-5
Empirical Formula: C13H13NO3S
Molecular Weight: 263.31
MDL number: MFCD03700424
EINECS: 605-268-8
Pack Size | Price | Stock | Quantity |
1G | RMB45.60 | In Stock |
|
5G | RMB104.80 | In Stock |
|
25g | RMB401.60 | In Stock |
|
100g | RMB849.60 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 180 ºC |
Boiling point: | 426.8±55.0 °C(Predicted) |
Density | 1.274 |
storage temp. | Sealed in dry,Room Temperature |
solubility | DMSO (Slightly), Methanol (Very Slightly) |
form | Solid |
pka | 8.56±0.15(Predicted) |
color | Off-White |
InChI | InChI=1S/C13H13NO3S/c1-3-17-13(16)11-8(2)14-12(18-11)9-4-6-10(15)7-5-9/h4-7,15H,3H2,1-2H3 |
InChIKey | LOCYSKNNFCGDTR-UHFFFAOYSA-N |
SMILES | S1C(C(OCC)=O)=C(C)N=C1C1=CC=C(O)C=C1 |
CAS DataBase Reference | 161797-99-5(CAS DataBase Reference) |
Description and Uses
Ethyl 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylate is used in the synthesis of the major metabolites of Febuxostat (F229000), a xanthine oxidase/xanthine dehydrogenase inhibitor. Used for treatment of hyperuricemia and chronic gout. 40-120 mg/day febuxostat was proven effective in lowering serum urate levels when administered to manage hyperuricemia in patients with gout.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H315-H319-H335 |
Precautionary statements | P261-P280a-P304+P340-P305+P351+P338-P405-P501a |